Search alternatives:
changed decrease » marked decrease (Expand Search), change increases (Expand Search), caused decreased (Expand Search)
significant cost » significant cause (Expand Search), significant amount (Expand Search), significant causal (Expand Search)
larger decrease » marked decrease (Expand Search)
cost decreased » costs decreased (Expand Search), costs increased (Expand Search), content decreased (Expand Search)
Showing 141 - 160 results of 30,881 for search '(( significantly ((changed decrease) OR (larger decrease)) ) OR ( significant cost decreased ))', query time: 0.89s Refine Results
  1. 141
    Each square gives extinction probability p (AB) or median population change d (CD) for 100 simulations at .

    Each square gives extinction probability p (AB) or median population change d (CD) for 100 simulations at . by Alexandra M. Campbell (3284094)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 142
    Changes of R<sup>2</sup> (NSEs) with different combinations containing different number of observed phenological datasets for calibration.

    Changes of R<sup>2</sup> (NSEs) with different combinations containing different number of observed phenological datasets for calibration. by Yonghui Zhang (279832)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  3. 143
    CBP per cumulative year for daratumumab and pembrolizumab per vial.

    CBP per cumulative year for daratumumab and pembrolizumab per vial. by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  4. 144
    S4 Fig -

    S4 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  5. 145
    S1 Fig -

    S1 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  6. 146
    S5 Fig -

    S5 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  7. 147
    S3 Fig -

    S3 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  8. 148
    S6 Fig -

    S6 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  9. 149
    CBP per cumulative indication for daratumumab and pembrolizumab per vial.

    CBP per cumulative indication for daratumumab and pembrolizumab per vial. by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  10. 150
    Inputs utilized in base-case and scenario analysis for daratumumab and pembrolizumab, both unadjusted and adjusted for PPP and inflation.

    Inputs utilized in base-case and scenario analysis for daratumumab and pembrolizumab, both unadjusted and adjusted for PPP and inflation. by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  11. 151
    Implementation of indication-based pricing (10<sup>th</sup> scenario) for daratumumab and pembrolizumab.

    Implementation of indication-based pricing (10<sup>th</sup> scenario) for daratumumab and pembrolizumab. by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  12. 152
    Input parameters for the base-case analysis.

    Input parameters for the base-case analysis. by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  13. 153
    S2 Fig -

    S2 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  14. 154
    S1 Data -

    S1 Data - by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  15. 155
    S1 Data -

    S1 Data - by Yi-xiao Liu (14769126)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  16. 156
    Number of patients with a significant increase or significant decrease between the baseline measurement (SCr-BL) and the creatinine measurement at emergency department presentation (SCr-ED).

    Number of patients with a significant increase or significant decrease between the baseline measurement (SCr-BL) and the creatinine measurement at emergency department presentation... by M. S. A. Niemantsverdriet (11886431)

    Published 2021
    Save to List
    Saved in:
  17. 157
    GLS inhibition decreases IL-1β secretion <i>in vitro</i>.

    GLS inhibition decreases IL-1β secretion <i>in vitro</i>. by Bárbara Ponzilacqua-Silva (17002156)

    Published 2025
    Save to List
    Saved in:
  18. 158
    Gut richness and diversity decrease significantly by week 5 of chemoradiotherapy.

    Gut richness and diversity decrease significantly by week 5 of chemoradiotherapy. by Molly B. El Alam (10231830)

    Published 2021
    Save to List
    Saved in:
  19. 159
    Results of Analysis of Co-variance (ANCOVA) for change in parameter predicted by treatment group with pre-treatment value as a covariate. * p < 0.05; ** p < 0.01.

    Results of Analysis of Co-variance (ANCOVA) for change in parameter predicted by treatment group with pre-treatment value as a covariate. * p < 0.05; ** p < 0.01. by Lijuan Liu (136685)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 160
    Top 20 genes with significantly decreased abundance in Aco<sup>R</sup> cells.

    Top 20 genes with significantly decreased abundance in Aco<sup>R</sup> cells. by Pieter C. Steketee (10024552)

    Published 2021
    Subjects:
    Save to List
    Saved in:

Search Tools: